Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,284.00
Bid: 2,287.00
Ask: 2,288.00
Change: 43.00 (1.92%)
Spread: 1.00 (0.044%)
Open: 2,247.00
High: 2,292.00
Low: 2,242.00
Prev. Close: 2,241.00
HLMA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

27 Sep 2017 07:00

RNS Number : 8921R
Halma PLC
27 September 2017
 

Halma plc

 

Trading Update

 

27 September 2017

 

Trading Update

 

Halma, the leading safety, health and environmental technology group today releases its scheduled Trading Update, relating to trading for the period from 2 April 2017.

 

Halma made good progress in line with the Board's expectations. The improved rates of organic constant currency revenue and profit growth achieved in the second half of the last financial year have continued into the current year. Order intake was ahead of revenue and also ahead of the same period last year.

 

There was widespread growth geographically, with organic constant currency revenue increases in all major regions. Asia Pacific maintained strong growth, with good progress in the UK and Mainland Europe and a steady performance in the USA.

 

The Environmental & Analysis sector performed particularly well, benefitting from strong growth in Asia Pacific and the re-organisation in its Life Science and Research business during the first half of last year.

 

The improved performance achieved by the Process Safety sector in the second half of last year continued. Market diversification and rising demand from the US onshore energy market both contributed to significant growth over the prior year.

 

The Infrastructure Safety sector continued to achieve good growth as greater investment in new product development in recent years contributed towards increasing demand from Asia Pacific and Mainland Europe.

 

The Medical sector also achieved solid revenue growth, although profitability was lower due to increased investment in new product development and sales resources.

 

In August 2017, we announced the acquisitions of Cardios for an initial consideration of R$50m (£12.1m) and CASMED for $4.5m (£3.4m). Both businesses strengthen our Medical sector's blood pressure monitoring technology base, with Cardios also being Halma's first acquisition in Brazil. The integration of both businesses is progressing well.

 

Our M&A pipeline strengthened during the period. We continue to search for businesses in, or adjacent to, all four sectors and the additional sector resources added during 2016 have improved both the quantity and quality of our opportunities.

 

Cash generation was good and the Group's financial position remains strong.

 

The results for the half year ending 30 September 2017 will be released on 21 November 2017.

 

 

 

 

For further information, please contact:

 

Halma plc Tel: +44 (0)1494 721111

Andrew Williams, Chief Executive

Kevin Thompson, Finance Director

 

MHP Communications Tel: +44 (0)20 3128 8100

Rachel Hirst/Andrew Jaques

 

 

Notes:

 

1.

This Trading Update is based on unaudited management accounts information and has been prepared solely to provide additional information to the shareholders of Halma plc. It should not be relied on by any other party, for other purposes. Forward-looking statements have been made by the Directors in good faith using information available up until the date that they approved this statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

 

2.

A copy of this announcement, together with other information about Halma, may be viewed on its website: www.halma.com

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBLGDCUDDBGRL
Date   Source Headline
22nd Jan 202012:58 pmRNSChange of Remuneration Committee Chair
29th Nov 20191:27 pmRNSDirector/PDMR Shareholding
25th Nov 20195:10 pmRNSDirector/PDMR Shareholding
19th Nov 201911:45 amRNSDividend Declaration
19th Nov 20197:00 amRNSHalf-year Report
2nd Oct 20195:02 pmRNSDirector/PDMR Shareholding
1st Oct 20197:00 amRNSSite Visit
25th Sep 20197:00 amRNSTrading Statement
29th Jul 20199:44 amRNSDirector/PDMR Shareholding
25th Jul 20196:27 pmRNSResult of AGM
25th Jul 20197:00 amRNSNotice of Board Change
15th Jul 201911:01 amRNSHolding(s) in Company
15th Jul 201910:38 amRNSCompletion of Acquisition
4th Jul 20192:09 pmRNSDirector/PDMR Shareholding
2nd Jul 20194:47 pmRNSDirector/PDMR Shareholding
2nd Jul 201910:34 amRNSHolding(s) in Company
21st Jun 201910:52 amRNSAnnual Financial Report
21st Jun 20197:00 amRNSAcquisition
11th Jun 20197:00 amRNSFinal Results
29th May 20194:00 pmRNSHolding(s) in Company
28th May 201912:59 pmRNSHolding(s) in Company
23rd May 201910:46 amRNSHolding(s) in Company
22nd May 20191:49 pmRNSHolding(s) in Company
21st May 20196:28 pmRNSHolding(s) in Company
17th May 20195:08 pmRNSHolding(s) in Company
13th May 201910:37 amRNSHolding(s) in Company
30th Apr 20199:33 amRNSHolding(s) in Company
17th Apr 201910:13 amRNSHolding(s) in Company
22nd Mar 20199:34 amRNSHolding(s) in Company
21st Mar 201912:30 pmRNSHolding(s) in Company
21st Mar 20197:00 amRNSTrading Statement
7th Feb 20192:00 pmRNSInvestor Event
18th Jan 20197:00 amRNSAcquisition
18th Dec 201811:02 amRNSDirector Declaration
20th Nov 20183:21 pmRNSDoc re. Half Year Report
20th Nov 20187:00 amRNSHalf-year Report
16th Nov 20187:00 amRNSAcquisition
19th Oct 20187:00 amRNSAcquisition
2nd Oct 20184:39 pmRNSDirector/PDMR Shareholding
27th Sep 20187:00 amRNSTrading Statement
2nd Aug 20183:29 pmRNSDirector/PDMR Shareholding
1st Aug 20185:23 pmRNSTotal Voting Rights
27th Jul 201810:39 amRNSDirector/PDMR Shareholding
19th Jul 20184:45 pmRNSResult of AGM
4th Jul 201810:25 amRNSDirector/PDMR Shareholding
26th Jun 20186:06 pmRNSDirector Declaration
19th Jun 20185:23 pmRNSAnnual Financial Report
12th Jun 20187:00 amRNSFinal Results
27th Mar 201810:02 amRNSDirector/PDMR Shareholding
22nd Mar 20187:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.